Novartis AG
DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS

Abstract:

Provided herein are immunoconjugates comprising an anti-DC-SIGN antibody conjugated to a STING agonist. Also disclosed are methods of making the immunoconjugates and methods of treating cancer using the immunoconjugates.